|
US6890539B2
(en)
|
1998-12-22 |
2005-05-10 |
Microscience, Ltd. |
Genes and proteins, and their use
|
|
PT1141308E
(pt)
|
1998-12-22 |
2007-05-31 |
Microscience Ltd |
Ptroteínas de streptococcus do grupo b e sua utilização
|
|
DK1328543T3
(da)
|
2000-10-27 |
2009-11-23 |
Novartis Vaccines & Diagnostic |
Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
|
|
JP4875490B2
(ja)
|
2003-07-31 |
2012-02-15 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
|
|
US8945589B2
(en)
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
|
WO2006042027A2
(en)
*
|
2004-10-08 |
2006-04-20 |
Novartis Vaccines And Diagnostics Inc. |
Immunogenic and therapeutic compositions for streptococcus pyogenes
|
|
EP1801235A1
(en)
|
2005-12-20 |
2007-06-27 |
Institut Pasteur |
Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
|
|
EP2029623A2
(en)
*
|
2006-06-19 |
2009-03-04 |
Mutabilis SA |
Identification of genes implicated in the virulence of streptococcus agalactiae
|
|
WO2009027768A2
(en)
*
|
2006-07-26 |
2009-03-05 |
Novartis Ag |
Immunogenic compositions for gram positive bacteria
|
|
CA2699513C
(en)
|
2007-09-12 |
2018-03-13 |
Novartis Ag |
Gas57 mutant antigens and gas57 antibodies
|
|
EP2135877A1
(en)
|
2008-06-19 |
2009-12-23 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
|
|
US8147849B2
(en)
|
2009-02-20 |
2012-04-03 |
Novartis Ag |
Protective antigens for group B Streptococcus hypervirulent strains
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
SG10201403702SA
(en)
|
2009-06-29 |
2014-09-26 |
Genocea Biosciences Inc |
Vaccines and compositions against streptococcus pneumoniae
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
US9393294B2
(en)
|
2011-01-20 |
2016-07-19 |
Genocea Biosciences, Inc. |
Vaccines and compositions against Streptococcus pneumoniae
|
|
JP5986931B2
(ja)
*
|
2011-02-02 |
2016-09-06 |
公益財団法人微生物化学研究会 |
血液脳関門を透過する薬物輸送体、ペプチド及びその用途
|
|
EP2557424A1
(en)
*
|
2011-08-11 |
2013-02-13 |
InGen Biosciences |
Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
|
|
RU2014138418A
(ru)
*
|
2012-02-24 |
2016-04-10 |
Новартис Аг |
Белки пилей и композиции
|
|
EP2831250B1
(en)
*
|
2012-03-30 |
2021-11-24 |
DuPont US Holding, LLC |
Enzymes useful for peracid production
|
|
AR092897A1
(es)
|
2012-10-03 |
2015-05-06 |
Novartis Ag |
Composiciones inmunogenicas
|
|
WO2015008214A1
(en)
*
|
2013-07-16 |
2015-01-22 |
Universite De Lausanne |
Bacterial lysins and uses thereof
|
|
AR101455A1
(es)
*
|
2014-08-05 |
2016-12-21 |
Glaxosmithkline Biologicals Sa |
Molécula portadora
|
|
ES2877754T3
(es)
|
2016-02-04 |
2021-11-17 |
Genovis Ab |
Nuevas proteasas estreptocócicas
|
|
US11028159B2
(en)
|
2017-05-02 |
2021-06-08 |
Venomyx, Inc. |
Composition and methods for treating snake envenomation
|
|
WO2018237010A2
(en)
*
|
2017-06-20 |
2018-12-27 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Vaccine compositions and methods of using the same
|
|
PL239045B1
(pl)
*
|
2018-01-09 |
2021-11-02 |
Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk |
Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
|
|
CA3268712A1
(en)
*
|
2018-06-13 |
2025-10-14 |
Gen-Probe Incorporated |
Compositions and Methods for Detecting Group B Streptococcus Nucleic Acid
|
|
MX2021001493A
(es)
|
2018-08-06 |
2021-07-15 |
Medikine Inc |
Compuestos de fijación al receptor de il-2.
|
|
KR20220110207A
(ko)
|
2019-11-05 |
2022-08-05 |
메디카인 인코포레이티드 |
IL-2RβγC 결합 화합물
|
|
WO2021108929A1
(en)
*
|
2019-12-06 |
2021-06-10 |
Theratechnologies Inc. |
Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer
|
|
IL295304A
(en)
|
2020-02-03 |
2022-10-01 |
Medikine Inc |
Il-7 receptor alpha gamma c binding compounds, compositions comprising same and uses thereof
|
|
AU2021219847A1
(en)
*
|
2020-02-12 |
2022-10-13 |
Massachusetts Institute Of Technology |
Field deployable CRISPR-Cas diagnostics and methods of use thereof
|
|
US11639523B2
(en)
|
2020-03-23 |
2023-05-02 |
The Broad Institute, Inc. |
Type V CRISPR-Cas systems and use thereof
|
|
WO2022026534A1
(en)
*
|
2020-07-28 |
2022-02-03 |
Kansas State University Research Foundation |
Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
|
|
KR20230097168A
(ko)
*
|
2020-11-04 |
2023-06-30 |
메디카인 인코포레이티드 |
IL-2Rβγc 결합 화합물 및 이의 용도
|
|
US11999771B2
(en)
|
2022-04-07 |
2024-06-04 |
Medikine, Inc. |
IL-7Rαγc ligand immunoglobulin fusion proteins
|
|
WO2025017062A1
(en)
*
|
2023-07-18 |
2025-01-23 |
Intervet International B.V. |
New type of streptococcus agalactiae serotype ia bacterium and vaccines thereof
|
|
TW202542195A
(zh)
*
|
2024-01-08 |
2025-11-01 |
美商得納利醫療公司 |
用於調節Ｔａｕ表現之組成物及方法
|
|
WO2025250877A1
(en)
*
|
2024-05-31 |
2025-12-04 |
Saliogen Therapeutics, Inc. |
Mobile genetic elements from myotis myotis
|